Companies House 12987779 2024-11-30 2024-11-30 2023-12-01 false iso4217:GBP xbrli:pure 12987779 2022-12-01 2023-11-30 12987779 2024-11-30 12987779 2023-12-01 2024-11-30 12987779 2023-11-30 12987779 curr:PoundSterling 2023-12-01 2024-11-30 12987779 uk-bus:CompanyLimitedByGuarantee 2023-12-01 2024-11-30 12987779 uk-bus:FRS102 2023-12-01 2024-11-30 12987779 uk-bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 12987779 uk-bus:FullAccounts 2023-12-01 2024-11-30 12987779 uk-bus:RegisteredOffice 2023-12-01 2024-11-30 12987779 uk-bus:Director1 2023-12-01 2024-11-30 12987779 uk-bus:Director2 2023-12-01 2024-11-30 12987779 uk-bus:Director3 2023-12-01 2024-11-30 12987779 uk-bus:Director4 2023-12-01 2024-11-30 12987779 uk-bus:Director5 2023-12-01 2024-11-30 12987779 uk-bus:Director6 2023-12-01 2024-11-30 12987779 uk-bus:Director7 2023-12-01 2024-11-30 12987779 uk-bus:Director8 2023-12-01 2024-11-30 12987779 uk-bus:Director9 2023-12-01 2024-11-30 12987779 uk-bus:Director10 2023-12-01 2024-11-30 12987779 uk-bus:Director11 2023-12-01 2024-11-30 12987779 uk-bus:Director12 2023-12-01 2024-11-30 12987779 uk-bus:Director13 2023-12-01 2024-11-30 12987779 uk-bus:Director14 2023-12-01 2024-11-30 12987779 uk-bus:Director15 2023-12-01 2024-11-30 12987779 uk-bus:Director16 2023-12-01 2024-11-30 12987779 uk-bus:Director17 2023-12-01 2024-11-30 12987779 uk-bus:Director18 2023-12-01 2024-11-30 12987779 uk-bus:Director19 2023-12-01 2024-11-30 12987779 uk-bus:Director20 2023-12-01 2024-11-30 12987779 uk-bus:Director21 2023-12-01 2024-11-30 12987779 uk-bus:CompanySecretary1 2023-12-01 2024-11-30 12987779 core:AfterOneYear 2024-11-30 12987779 core:AfterOneYear 2023-11-30 12987779 core:WithinOneYear 2024-11-30 12987779 core:WithinOneYear 2023-11-30 12987779 core:WithinOneYear 2023-12-01 2024-11-30 12987779 core:AfterOneYear 2024-11-30 12987779 core:AfterOneYear 2023-11-30 12987779 core:AfterOneYear 2023-12-01 2024-11-30 12987779 core:ShareCapital 2024-11-30 12987779 core:ShareCapital 2023-11-30 12987779 core:SharePremium 2024-11-30 12987779 core:SharePremium 2023-11-30 12987779 core:OtherReservesSubtotal 2024-11-30 12987779 core:OtherReservesSubtotal 2023-11-30 12987779 core:RevaluationReserve 2024-11-30 12987779 core:RevaluationReserve 2023-11-30 12987779 core:RetainedEarningsAccumulatedLosses 2024-11-30 12987779 core:RetainedEarningsAccumulatedLosses 2023-11-30 12987779 1 2023-12-01 2024-11-30 12987779 2 2023-12-01 2024-11-30 12987779 3 2023-12-01 2024-11-30 12987779 core:LandBuildings 2023-12-01 2024-11-30 12987779 core:LandBuildings 2024-11-30 12987779 core:LandBuildings 2022-12-01 2023-11-30 12987779 core:LandBuildings 2023-11-30 12987779 core:PlantMachinery 2023-12-01 2024-11-30 12987779 core:PlantMachinery 2024-11-30 12987779 core:PlantMachinery 2022-12-01 2023-11-30 12987779 core:PlantMachinery 2023-11-30 12987779 core:FurnitureFittingsToolsEquipment 2023-12-01 2024-11-30 12987779 core:FurnitureFittingsToolsEquipment 2024-11-30 12987779 core:FurnitureFittingsToolsEquipment 2022-12-01 2023-11-30 12987779 core:FurnitureFittingsToolsEquipment 2023-11-30 12987779 core:OfficeEquipment 2023-12-01 2024-11-30 12987779 core:OfficeEquipment 2024-11-30 12987779 core:OfficeEquipment 2022-12-01 2023-11-30 12987779 core:OfficeEquipment 2023-11-30 12987779 core:Vehicles 2023-12-01 2024-11-30 12987779 core:Vehicles 2024-11-30 12987779 core:Vehicles 2022-12-01 2023-11-30 12987779 core:Vehicles 2023-11-30 12987779 core:NetGoodwill 2023-12-01 2024-11-30 12987779 core:NetGoodwill 2024-11-30 12987779 core:NetGoodwill 2022-12-01 2023-11-30 12987779 core:NetGoodwill 2023-11-30 12987779 core:IntangibleAssetsOtherThanGoodwill 2023-12-01 2024-11-30 12987779 core:IntangibleAssetsOtherThanGoodwill 2024-11-30 12987779 core:IntangibleAssetsOtherThanGoodwill 2022-12-01 2023-11-30 12987779 core:IntangibleAssetsOtherThanGoodwill 2023-11-30

# CHILL THERAPY CIC

## Company limited by guarantee

## Company Registration Number:
12987779 (England and Wales)

## Unaudited statutory accounts for the year ended 30 November 2024

## Period of accounts

## Start date: 1 December 2023

## End date: 30 November 2024

# CHILL THERAPY CIC

## Contents of the Financial Statements

for the Period Ended 30 November 2024

Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# CHILL THERAPY CIC

## Profit And Loss Account

for the Period Ended 30 November 2024

| 2024 | 2023
--- | --- | ---
| £ | £
Turnover: | 41,509 | 35,597
Cost of sales: | ( 21,188 ) | ( 29,487 )
Gross profit(or loss): | 20,321 | 6,110
Administrative expenses: | ( 35,142 ) |
Operating profit(or loss): | (14,821) | 6,110
Profit(or loss) before tax: | (14,821) | 6,110
Tax: | 1,161 | ( 1,161 )
Profit(or loss) for the financial year: | (13,660) | 4,949

# CHILL THERAPY CIC

## Balance sheet

As at 30 November 2024

| Notes | 2024 | 2023
--- | --- | --- | ---
|  | £ | £
Current assets
Debtors: | 3 | 6,436 | 10,907
Cash at bank and in hand: |  | 947 | 21,006
Total current assets: |  | 7,383 | 31,913
Creditors: amounts falling due within one year: | 4 | ( 85 ) | ( 1,161 )
Net current assets (liabilities): |  | 7,298 | 30,752
Total assets less current liabilities: |  | 7,298 | 30,752
Creditors: amounts falling due after more than one year: | 5 |  | ( 9,794 )
Total net assets (liabilities): |  | 7,298 | 20,958
Members' funds
Profit and loss account: |  | 7,298 | 20,958
Total members' funds: |  | 7,298 | 20,958

The notes form part of these financial statements

# CHILL THERAPY CIC

## Balance sheet statements

For the year ending 30 November 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 6 October 2025
and signed on behalf of the board by:

Name: Michael Morris
Status: Director

The notes form part of these financial statements

# CHILL THERAPY CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2024

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# CHILL THERAPY CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2024

- ## 2. Employees

  | 2024 | 2023
  --- | --- | ---
  Average number of employees during the period | 1 | 1

# CHILL THERAPY CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2024

## 3. Debtors

| 2024 | 2023
--- | --- | ---
| £ | £
Trade debtors | 6,436 | 10,907
Total | 6,436 | 10,907

# CHILL THERAPY CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2024

## 4. Creditors: amounts falling due within one year note

| 2024 | 2023
--- | --- | ---
| £ | £
Trade creditors |  | 1,161
Other creditors | 85 |
Total | 85 | 1,161

# CHILL THERAPY CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2024

## 5. Creditors: amounts falling due after more than one year note

|  | 2023
--- | --- | ---
|  | £
Other creditors |  | 9,794
Total |  | 9,794

# COMMUNITY INTEREST ANNUAL REPORT

### CHILL THERAPY CIC

### Company Number: 12987779 (England and Wales)

### Year Ending: 30 November 2024

Company activities and impact

Chill Therapy CIC is a not for profit organisation, dedicated to provide open water swim courses for people experiencing anxiety and depression and other related illnesses. By providing these courses, we are bringing communities together, combatting loneliness and also making the sea more accessible for all, especially minorities and locals who are on low income and in areas of high deprivation. Chill Therapy CIC is also dedicated in setting up Chill Hubs nationally. We are engaged in educating the community in the benefits of cold water therapy and are dedicated in communicating with, and having referrals from local GPs and Social Prescribers.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

The total amount paid or receivable by directors in respect of qualifying services was £17,150. There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
6 October 2025

And signed on behalf of the board by:
Name: Michael Morris
Status: Director